Renal Function Test Market

Technological Advancements providing Early Disease Identification & Diagnosis of Specific Conditions

Prevalence of chronic kidney disease is witnessing a surge globally on the back of unhealthy lifestyle of people. This has prompted clinicians in using renal function tests in order to diagnose various kidney-related diseases. Technological advancements in the renal function tests has provided early disease identification, and diagnosis of specific conditions.

Some of these advancements include computer-assisted interpretation, usage of automated analyzers, and advanced parameter estimation, which have offered numerous benefits such as efficient parameter monitoring, automatic variable adjustment, enabling real-time automation, and greater process control. These tools also deliver analysis of a wide variety of samples, providing rapid results, thereby reflecting their potential applications in emergency wards, outpatient clinics and hospitals in the foreseeable future.

Private and public healthcare organizations are increasingly taking initiatives and providing recommendations, in a bid to attain efficient management of chronic kidney disease. For example – the CDC has launched the Chronic Kidney Disease (CKD) Initiative, which is dedicated to developing exhaustive public strategies and promoting awareness for curbing down the incidences of CKD. Initiatives such as this encourage clinicians in using early diagnostic procedures such as renal function test, which in turn influences expansion of the market.

According to a recently compiled report of Future Market Insights (FMI), the global market for renal function test will ride on a steady CAGR through the forecast period (2017-2026). Over US$ 900 Mn revenues are estimated to be amassed from worldwide usage of renal function tests by 2026-end.

North America to Remain Largest Market for Renal Function Test

Presence of highly supportive government initiatives, along with their consistent implementation by several healthcare organizations have led to a widespread awareness and adoption of renal function tests in North America. North America will remain the largest market for renal function test, in terms of revenues. Asia-Pacific excluding Japan (APEJ) is projected to register the fastest expansion in the global renal function test market through 2026.

This mainly because of robust outsourcing of contracts by leading market players to organizations in APEJ countries, such as China and India. In addition, gradual rise in investment for research & development activities by the region’s market players, and potential untapped opportunities will drive the market expansion in APEJ in the near future.

Key Research Findings from FMI’s Report on Renal Function Test Market

• Dipsticks will continue to be sought-after among products in the global renal function test market
• Hospitals will remain the most attractive end-users of renal function tests
• Microalbumin renal function test will be the fast expanding test type segment in the market during the forecast period

Competition Tracking

The global renal function test market is expected to witness an extensive competition on the back of increasing collaborative strategies between key companies for obtaining a competitive edge. New product development, high R&D investment, and mergers & acquisitions are other key strategies adopted by players in the market. Key market participants identified by FMI’s report include Siemens, Beckman Coulter, Roche, Abbott, Sysmex, Nova Biomedical, Urit Medical, Acon Laboratories, Elektronika, and Randox Laboratories.

Market Taxonomy

Region

• North America
• Latin America
• Europe
• Japan
• APEJ
• MEA

Product Type

• Dipsticks
• Disposables
• Reagents

End User

• Hospitals
• Diagnostic Laboratories
• Research Laboratories and Institutes
• Other End Users

Test Type

• Urine Protein
• Microalbumin
• Creatinine Clearance
• Serum Creatinine
• Other Test